RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Study protocol for the effects of formula diet with dapagliflozin on metabolic improvement and body composition in type 2 diabe

Nutrition
Endocrinology
Author
Y Watanabe et al.
Used Parameters : BFM
Publication Year : 2018
Country : Japan
Journal : Diabetes Therapy
Introduction Sodium-dependent glucose transporter-2 (SGLT2) inhibitors such as dapagliflozin induce weight loss, but the mechanism is thought to involve loss of both body fat and skeletal muscle mass. The decrease in skeletal muscle mass may lead to worsening of insulin resistance in type 2 diabetes patients. On the other hand, formula diet (FD) is a low-calorie food containing low carbohydrates, low fat, and sufficient protein, vitamins, and minerals to support a healthy and balanced diet, and is used for the treatment of obesity or …
Full text
List
Powered by KBoard